Increased focus on providing optimum patient care in the
most cost efficient way is fuelling demand for intelligent infusion devices
termed “Smart Pumps.” A report from InMedica, a division of IMS Research (recently
acquired by IHS Inc.), on the global market for infusion pumps found that,
despite market saturation in the developed countries, demand for advanced
technology is being maintained; infusion pump suppliers must offer technically
advanced products at competitive prices to maintain market share. Smart
pumps with software to reduce the risk of dose error in IV therapy, to provide
safer patient care, is becoming increasingly important, in the light of
reimbursement restrictions for “never events” in U.S. hospitals. InMedica
predicts the U.S.
market for large-volume infusion pumps will increase to $500 million by 2015.
“Medication errors, during prescription, preparation or
administration of medication, can lead to adverse drug events (ADEs). According
to the National Health Service (NHS) in the U.K., intravenous (IV) pumps can
account for up to 35 percent of medication errors,” comments Kelly Barritt of
“It is becoming more apparent that systems need to be
implemented to prevent such errors from occurring. Dose error reduction
software is designed to check the information a physician programmes into a
pump against the limits set by the drug library; the care-giver is then alerted
of an error before infusion starts,” continues Kelly Barritt, Senior Market
Analyst. As provision of care becomes increasingly pressured, with nurses and
physicians often working long hours to meet patient demand, smart pumps will
help to reduce errors. Customers will favour products with higher levels
of harm-reduction software to eliminate ADEs; use of the next generation of
‘Smart’ pumps will grow quickly. In addition, the number of devices for home
use incorporating safety features is also increasing, further driving growth in
Furthermore, in an attempt to drive down the cost of
treatment, patient care is being transferred to lower-acuity departments and in
some instances to the home; technology is developing as a result.
Radiofrequency identification (RFID) chips have been installed by some
manufacturers in infusion pumps, to allow healthcare institutions to track
their location. The RFID chips enable pumps to be quickly accessed, reducing
the search times in large hospitals. Device tracking may also be successful in
home-care environments, enabling the home-care agencies to monitor the
locations of the pumps on loan.
These trends and more are also discussed in InMedica’s
report, “The World Market for Infusion Pumps and Accessories – 2011 edition”.
For more details, please visit www.in-medica.com.